$CYTR Company News Six stocks to watch 3:29 p.m. Jan.

New Post Public Reply Private Reply Replies (0) Message Board

Aug 24, 2014 at 12:24 PM

$CYTR Company News

Six stocks to watch 3:29 p.m. Jan. 22, 2014 - The Trading Deck
CytRx's stock spike proves to be no fluke with another 20% share gain 12:39 p.m. Dec. 12, 2013 - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 5:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 10:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 6:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 11:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 12:49 p.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 11:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 2:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 9:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 2:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 8:50 a.m. Jan. 22, 2008 - Angela Moore

Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Five Analyst Stock Picks With 100% or More Implied Upside 8:31 a.m. June 7, 2014 - 247WallSt.com
Celldex: The Race Leader In Glioblastoma Multiforme 3:17 p.m. May 29, 2014 - Seeking Alpha
Aldoxorubicin increases PFS 7:53 a.m. May 28, 2014 - Seeking Alpha
Six Unusual Hot Stocks on the Move Monday Morning 8:14 a.m. May 5, 2014 - 247WallSt.com
Interesting CYTR Put And Call Options For December 20th 12:51 p.m. April 22, 2014 - TheStreet.com
CytRx shares pop premarket 8:32 a.m. April 3, 2014 - Seeking Alpha
CytRx drug for soft-tissue sarcomas gets orphan status in Europe 8:21 a.m. March 31, 2014 - Seeking Alpha
Behind The Scenes With Proactive, Inovio And Unilife 9:45 a.m. March 27, 2014 - Seeking Alpha
Stock Pumping Is Tainting Many Financial Websites 1:30 p.m. March 25, 2014 - Barrons.com
Seeking Alpha Needs to Take Stock of its Policies 10:07 a.m. March 24, 2014 - Barrons.com
Galena: A Good Investment Gone Bad 9:02 a.m. March 18, 2014 - Seeking Alpha
An Insider's Tale of a Stock Promotion Plan 7:39 p.m. March 14, 2014 - Barrons.com
Behind The Scenes With Dream Team, CytRx And Galena 9:30 a.m. March 13, 2014 - Seeking Alpha
CytRx set to begin phase 3 clinical trial for aldoxorubicin 8:33 a.m. March 5, 2014 - Seeking Alpha
10-K: CYTRX CORP 7:04 a.m. March 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
CytRx's Aldoxorubicin's Potential Is Underestimated, Creating A Buying Opportunity 10:06 a.m. Feb. 7, 2014 - Seeking Alpha
CytRx Flushed Its Shareholders, Even If It Needed the Capital 8:16 a.m. Feb. 1, 2014 - 247WallSt.com

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx CorporationRegarding Possible Breaches of Fiduciary Duty 6:03 p.m. Aug. 11, 2014 - BusinessWire - BZX
Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies 9:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma Highlighted in The Lancet Oncology 6:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
CytRx Reports 2014 Second Quarter Financial Results 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire for More Information -- CYTR 6:00 p.m. Aug. 5, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx Corporation Regarding Possible Breaches of Fiduciary Duty 6:56 p.m. July 9, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics 6:40 a.m. June 30, 2014 - PR Newswire - PRF
CytRx Added to Russell 3000® and Russell 2000® Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
CytRx to Present at the Jefferies 2014 Global Healthcare Conference 6:01 a.m. May 29, 2014 - BusinessWire - BZX
CytRx Highlights Aldoxorubicin Data from its Global Phase 2b Clinical Trial in First-Line Soft Tissue Sarcoma 6:01 a.m. May 28, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR 6:15 p.m. May 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR 11:46 a.m. May 8, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR 12:33 p.m. May 6, 2014 - GlobeNewswire
Hagens Berman: 7 Days Remain Until May 13, 2014 Lead Plaintiff Deadline in CytRx Securities Fraud Class Action 12:26 p.m. May 6, 2014 - PR Newswire - PRF
CytRx Reports Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data in Second-Line Soft Tissue Sarcoma 6:01 a.m. May 5, 2014 - BusinessWire - BZX
Pre-Market Review on Top Gainers -- Research on SouFun Holdings, CytRx, Iridium Communications, and Qihoo 360 Technology 8:12 a.m. May 2, 2014 - PR Newswire - PRF
CYTRX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytRx Corporation - CYTR 10:01 p.m. May 1, 2014 - GlobeNewswire
CytRx Reports 2014 First Quarter Financial Results 6:02 a.m. May 1, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vensure Launches Nationwide Background Casting Service

Vensure Dives into the World of Background Casting You ever consider just how chaotic a film or TV set can get? One minute things are all glitz and glam, and the next, it's pure mayhem as everything descends into a frenzied dance of coordination chaos. That's the circus of background casting for ya. Vensure's latest venture, Vensure Casting, throws its hat in the ring,...

Customized Anti-Aging Plans Revealed: Botox to Microneedling

Intricacies of Aging: Beyond One-Size-Fits-All So you've hit a point in life where those wrinkles and sagging skin aren't just brushing off with a night's sleep. Enter Dr. Sherif Salama with his treasure trove of options fitting for the fussy nature of skin. The Aging Conundrum: Multifaceted Challenges Aging isn't a one-trick pony. Wrinkles crop up, volume disappears,...

Tom Doyle Takes Helm at Gallagher's HR Consulting

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Winter Roof Woes: How to Handle Ice and Snow Load

Understanding Roof Load Limits You don't have to be in the roofing business to know that Central NY doesn't mess around when winter hits. Michael Majeski, a name trusted in Watertown, NY, is sounding the alarm on how snow and ice can either shake a roof or break it. Talking about roof 'load limits' might sound all fancy, but in plain talk, it's about knowing when your...

SightMD Adds Top Cornea Specialist to Yonkers Team

Expanding Expertise in Westchester Today's eye care landscape just got a bit tighter up in Yonkers. SightMD's hauled in a new ace—Dr. Brittany M. Perzia. This isn't your run-of-the-mill hire. The good doctor packs a solid punch in Cornea & External Disease, aiming her skills at the folks around Westchester. It's not just about the numbers with her, though. Her resume's...

Qapture's Institutional Stablecoin Venture Unveiled

Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...

Independents' Election Broadcast: A Historic Shift

Independents Take Center Stage on Election Night 2026 Over the years, I've seen plenty of unexpected movements in the market, but this is something unique—a seismic shift, not in finance, but in the political landscape. Election Night 2026 is shaping up to be a real game-changer, as independents step away from the sidelines and demand attention. It's a first-of-its-kind...

MemorialCare Expands Cutting-Edge GERD Treatment Options

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

PATEO Drives In-Car AI Forward with NVIDIA Power

Revolutionizing In-Vehicle AI with Big Names Boy, driving ain't what it used to be, and PATEO's latest adventure has a lot to do about it. They've hooked up with some major players like NVIDIA and ByteDance to really shake up the in-car AI scene. We're not just talking bells and whistles, but a true reinvention trying to blend AI straight into our daily grind on the road....

VAB's Pharma Ad Guide: Emerging Trends and Insights

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...